Criteria for treatment of neonatal jaundice

Journal of Perinatology

Volumn 21, Issue , 2001, Pages S88-S92

  Bratlid, Dag ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; MESOPORPHYRIN TIN; PHENOBARBITAL;

ANTIOXIDANT ACTIVITY; ATTITUDE; BILIRUBIN BLOOD LEVEL; CLINICAL PRACTICE; CONFERENCE PAPER; CYTOTOXICITY; DISEASE DURATION; DISEASE PREDISPOSITION; ENZYME INDUCTION; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE PERSONNEL; HUMAN; HYPERBILIRUBINEMIA; INFANT; KERNICTERUS; LOW BIRTH WEIGHT; MEDICAL ASSESSMENT; NEWBORN; NEWBORN JAUNDICE; PHOTOTHERAPY; PREMATURITY; TREATMENT PLANNING; VALIDATION PROCESS;

BILIRUBIN; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; JAUNDICE, NEONATAL; KERNICTERUS; PHOTOTHERAPY;

EID: 0035687332     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/sj.jp.7210656     Document Type: Article

References (22)

1. Maisels MJ. Bilirubin. On understanding and influencing its metabolism in the newborn infant. Pediatr Clin N Am 1972;19:447.
2. Jährig K, Jährig L, Meisel P. (eds). Phototherapy. Treating Neonatal Jaundice with Visible Light. Munich: Quintessenz Verlag; 1993.
3. Maisels MJ. Clinical studies on the sequelae of hyperbilirubinemia. In Levine RL, Maisels MJ, editors. Hyperbilirubinemia in the Newborn. Report of the 85th Ross Conference on Pediatric Research. Columbus, Ohio; 1983. p. 26-38.
4. Bhutani VK, Gourley GR, Adler S, Kreamer B, et al. Noninvasive measurement of total serum bilirubin in a multiracial predischarge newborn population to assess the risk of severe hyperbilirubinemia. Pediatrics 2000;106:e17.
5. Tayaba R, Gribetz D, Gribetz I, Holzman IR. Noninvasive estimation of serum bilirubin. Pediatrics 1998;102:e28.
6. Americam Academy of Pediatrics Practice Parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics 1994;94:558.
7. Johnson L, Bhutani K. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol 1998;25:555.
8. Hansen TWR. Therapeutic approaches to neonatal jaundice. An international survey. Clin Pediatr 1996;35:309.
9. Cashore WJ. Bilirubin and jaundice in the micropremie. Clin Perinatol 2000;27:171.
10. Bratlid D. How bilirubin gets into the brain. Clin Perinatol 1990;17:449.
11. Nakamura H, Yonetani M, Uetani Y, Funato M, et al. Determination of unbound bilirubin for prediction of kernicterus in low birthweight infants. Acta Paediatr Jpn 1992;34:642.
12. Cashore WJ. Bilirubin binding tests. In Levine RL, Maisels MJ, editors. Hyperbilirubinemia in the Newborn. Report of the 85th Ross Conference on Pediatric Research. Columbus, Ohio; 1983. p. 101-10.
13. Stevenson DK, Vreman HJ. Carbon monoxide and bilirubin production in neonates. Pediatrics 1997;100(2):252.
14. Slusher TM, Vreman HJ, McLaren DW, Stevenson DK. Carboxyhemoglobin predicts bilirubin-related morbidity and mortality in infants. Pediatr Res 1993;33:237A.
15. Funato M, Tamai H, Shimada S, Nakamura H. Vigintiphobia, unbound bilirubin, and brainstem responses. Pediatrics 1994;93:50.
16. Vohr BR. New approaches to assessing the risks of hyperbilirubinemia. Clin Perinatol 1990;17:293.
17. Brodersen R. Prevention of kernicterus, based on recent progress in bilirubin chemistry. Acta Paediatr Scand 1977;66:625.
18. Bratlid D. Bilirubin toxicity: pathophysiology and assessment of risk factors. NY State J Med 1991;91:489.
19. Rubaltelli FF. Current drug treatment options in neonatal hyperbilirubinemia and the prevention of kernicterus. Drugs 1998;56:23.
20. Watchko JF, Daood MJ, Hansen TW. Brain bilirubin content is increased in P-glycoprotein-deficient transgenic null mice. Pediatr Res 1998;44:763.
21. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: A kinder, gentler approach. Pediatrics 1992;89:809.
22. Seidman DS, Moise J, Ergaz Z, Laor A, et al. A new blue light-emitting phototherapy device: A prospective randomized controlled study. J Pediatr 2000;136:771.